HeadInvest LLC’s Quest Diagnostics DGX Stock Holding History

HeadInvest LLC’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$36.3K	–	336
2023 Q3	$36.3K	Buy	+300	New	+$40K	0.01%	386

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HeadInvest LLC's DGX Position: Q4 2023 in Review

HeadInvest LLC sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 300 shares — an estimated $36.3K sold.

HeadInvest LLC first reported a position in DGX in Q3 2023 and held it in 1 quarter. The position peaked at $36.3K in Q3 2023. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

HeadInvest LLC reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 300 Quest Diagnostics shares in Q4 2023, an estimated $36.3K.
HeadInvest LLC first reported a position in Quest Diagnostics in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's Quest Diagnostics position peaked at $36.3K in Q3 2023.
826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.